Updates and media releases

Dechra seeks clearance to acquire Osurina from Elanco

The Commission has received a clearance application from Dechra Pharmaceuticals PLC, Dechra Limited and Dechra Veterinary Products LLC seeking clearance to acquire from Elanco Tiergesundheit AG its worldwide assets, rights and liabilities relating to Osurnia, a treatment for otitis in dogs. Read more
See all media releases

Commission videos